This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Guiseppe Granata: Innovator in Ocular Disease Treatments
Introduction
Guiseppe Granata is a notable inventor based in Acireale, Italy. He has made significant contributions to the field of ocular disease treatment through his innovative formulations. With a total of 2 patents, Granata's work focuses on enhancing the delivery of active ingredients for therapeutic purposes.
Latest Patents
Granata's latest patents include groundbreaking formulations designed for the delivery of silibinin and other active ingredients aimed at treating ocular diseases. These formulations incorporate silibinin within lipid nanoparticle systems of the SLN and NLC type, utilizing calixarenes that may be mucoadhesive. Additionally, they employ micellar and nanoparticle systems based on amphiphilic inulin copolymers. The versatility of the calixarene compound is highlighted, as it can charge and release active ingredients that are characterized by low water solubility, easy chemical and enzymatic degradation, and low bioavailability. This innovation is particularly relevant for the treatment of neurodegenerative ocular diseases.
Career Highlights
Guiseppe Granata is associated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where he continues to develop his innovative ideas. His work is instrumental in advancing the field of ocular therapeutics, showcasing his commitment to improving patient outcomes.
Collaborations
Granata collaborates with esteemed colleagues such as Grazia Maria Letizia Consoli and Giovanna Pitarresi. Their combined expertise contributes to the success of their research and development efforts.
Conclusion
Guiseppe Granata stands out as an influential inventor in the realm of ocular disease treatment. His innovative formulations and collaborative efforts are paving the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile